| Tau protein liquid–liquid phase separation can initiate tau aggregation S Wegmann, B Eftekharzadeh, K Tepper, KM Zoltowska, RE Bennett, ... The EMBO journal 37 (7), e98049, 2018 | 822 | 2018 |
| Tau PTM profiles identify patient heterogeneity and stages of Alzheimer’s disease H Wesseling, W Mair, M Kumar, CN Schlaffner, S Tang, P Beerepoot, ... Cell 183 (6), 1699-1713. e13, 2020 | 436 | 2020 |
| Tau protein disrupts nucleocytoplasmic transport in Alzheimer’s disease B Eftekharzadeh, JG Daigle, LE Kapinos, A Coyne, J Schiantarelli, ... Neuron 99 (5), 925-940. e7, 2018 | 380 | 2018 |
| Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo MA Busche, S Wegmann, S Dujardin, C Commins, J Schiantarelli, ... Nature neuroscience 22 (1), 57-64, 2019 | 354 | 2019 |
| What is the evidence that tau pathology spreads through prion-like propagation? A Mudher, M Colin, S Dujardin, M Medina, I Dewachter, SM Alavi Naini, ... Acta neuropathologica communications 5, 1-20, 2017 | 340 | 2017 |
| Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease S Dujardin, C Commins, A Lathuiliere, P Beerepoot, AR Fernandes, ... Nature medicine 26 (8), 1256-1263, 2020 | 326 | 2020 |
| Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies M Tardivel, S Bégard, L Bousset, S Dujardin, A Coens, R Melki, L Buée, ... Acta neuropathologica communications 4, 1-14, 2016 | 285 | 2016 |
| Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies S Dujardin, K Lécolle, R Caillierez, S Bégard, N Zommer, C Lachaud, ... Acta neuropathologica communications 2, 1-14, 2014 | 265 | 2014 |
| Ectosomes: a new mechanism for non-exosomal secretion of tau protein S Dujardin, S Bégard, R Caillierez, C Lachaud, L Delattre, S Carrier, ... PloS one 9 (6), e100760, 2014 | 247 | 2014 |
| Enhanced tau aggregation in the presence of amyloid β RE Bennett, SL DeVos, S Dujardin, B Corjuc, R Gor, J Gonzalez, AD Roe, ... The American journal of pathology 187 (7), 1601-1612, 2017 | 222 | 2017 |
| CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia H Makishima, AM Jankowska, MA McDevitt, C O'Keefe, S Dujardin, ... Blood, The Journal of the American Society of Hematology 117 (21), e198-e206, 2011 | 187 | 2011 |
| From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy M Colin, S Dujardin, S Schraen-Maschke, G Meno-Tetang, C Duyckaerts, ... Acta neuropathologica 139 (1), 3-25, 2020 | 158 | 2020 |
| Selection of an efficient AAV vector for robust CNS transgene expression KS Hanlon, JC Meltzer, T Buzhdygan, MJ Cheng, M Sena-Esteves, ... Molecular Therapy-Methods & Clinical Development 15, 320-332, 2019 | 117 | 2019 |
| Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo SL DeVos, BT Corjuc, C Commins, S Dujardin, RN Bannon, D Corjuc, ... Brain 141 (7), 2194-2212, 2018 | 99 | 2018 |
| Different tau species lead to heterogeneous tau pathology propagation and misfolding S Dujardin, S Bégard, R Caillierez, C Lachaud, S Carrier, S Lieger, ... Acta neuropathologica communications 6, 1-12, 2018 | 95 | 2018 |
| Invited review: animal models of tauopathies and their implications for research/translation into the clinic S Dujardin, M Colin, L Buée Neuropathology and applied neurobiology 41 (1), 59-80, 2015 | 89 | 2015 |
| Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism JM Cooper, A Lathuiliere, M Migliorini, AL Arai, MM Wani, S Dujardin, ... Journal of Biological Chemistry 296, 2021 | 65 | 2021 |
| Tau prion-like propagation: state of the art and current challenges S Dujardin, BT Hyman Tau Biology, 305-325, 2020 | 64 | 2020 |
| In vivo detection of tau fibrils and amyloid β aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy M Calvo-Rodriguez, SS Hou, AC Snyder, S Dujardin, H Shirani, ... Acta neuropathologica communications 7, 1-10, 2019 | 47 | 2019 |
| Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain R Caillierez, S Bégard, K Lécolle, V Deramecourt, N Zommer, S Dujardin, ... Molecular Therapy 21 (7), 1358-1368, 2013 | 47 | 2013 |
Bradley HymanMassachusetts General Hospital, Harvard Medical School在 partners.org 的电子邮件经过验证
